Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02127073 · ClinicalTrials.gov registry record · Phase 2
Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer
A Phase 2 study, sponsored by Montefiore Medical Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 8
- Enrollment target
NCT02127073 is a Phase 2 study that was terminated before completion, run by Montefiore Medical Center. The registered enrollment target is 8 participants.
The verdict
NCT02127073, a Phase 2 study, was terminated before completion, sponsored by Montefiore Medical Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the genetic material called microRNA of three types of specimens from women with breast cancer. The study also seeks to examine the effectiveness of using a new agent called oxytocin to increase the amount of nipple fluid that can be collected during surgery.
Interventions
- DRUG Intranasal Oxytocin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2015-01-30 |
| Est. Completion | 2017-09-18 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02127073
The ClinicalTrials.gov registry entry for NCT02127073 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intranasal Oxytocin is the first listed.
NCT02127073 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02127073 about?
NCT02127073 is a clinical study titled "Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer". The purpose of this study is to examine the genetic material called microRNA of three types of specimens from women with breast cancer. The study also seeks to examine the effectiveness of using a new agent called oxytocin to increase the amount of nipple fluid that can be collected during surgery.
What is the current status of trial NCT02127073?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 8 participants. The study started on 2015-01-30. Estimated completion is 2017-09-18.
What interventions are being tested in trial NCT02127073?
The interventions under investigation include: Intranasal Oxytocin (DRUG).
Who is sponsoring clinical trial NCT02127073?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.